Maintenance notice: Some features that submit or update information are temporarily disabled while we migrate the website. You can continue browsing normally. Thank you for your understanding.
Tissue Regenix Group plc
("Tissue Regenix" or "the Group")
World's first OrthoPure™ XT (dCELL® Tendon) implants successfully undertaken at Barcelona Hospital
York 4th December 2015, Tissue Regenix Ltd, (AIM:TRX) "Tissue Regenix" or "The Group" the regenerative medical device company, is pleased to announce that two patients have received the first OrthoPure™ XT decellularised tendons using Tissue Regenix patented dCELL® technology. This has been done as part of a clinical safety study by Tissue Regenix which is being conducted to secure a CE mark to enable launch of the OrthoPure™ XT in the EU in 2017.
Orthopaedic & Trauma Surgeon, Dr.
If you have orthopedic information that you would like to share with the Orthogate Community, please register/login and submit your news, event, job, article, case or workshop from the Submit Content menu under the My Account area. Learn more!
Improving orthopaedic care, education and research using Internet technologies